メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
池田 真理子
臨床遺伝科
h-index
1582
被引用数
21
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2003
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(79)
類似のプロファイル
(6)
フィンガープリント
Mariko Taniguchi-Ikedaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Biochemistry, Genetics and Molecular Biology
Fukutin
100%
Chromosomal Rearrangement
52%
Dystroglycan
52%
Fibronectin
52%
Dystroglycanopathy
52%
Antisense
42%
Oligonucleotide
42%
Allele
42%
Autosomal Recessive Inheritance
35%
Eicosanoid Receptor
30%
Variable Number Tandem Repeat
30%
Chromosome Instability
26%
Stem Cell
26%
Rigidity
26%
Glycosylphosphatidylinositol
26%
Motor Performance
26%
CRISPR Interference
26%
LARGE
26%
Heart Left Ventricle Ejection Fraction
26%
Dystrophin
26%
Alpha Chain
26%
Conformation
26%
Uniparental Disomy
26%
Exon Trapping
26%
RNA Sequence
26%
Dent's Disease
26%
Genetics
26%
Chromosome 11 (Human)
26%
Mosaicism
26%
Genetic Screening
26%
MKKS
26%
Next Generation Sequencing
26%
COL4A5
26%
Point Mutation
26%
Therapeutic Research
26%
DLL4
26%
Promoter Region
26%
Cell Proliferation
26%
Skeletal Muscle
26%
Heme Oxygenase
26%
in Vitro Gene Transfer
26%
Bartter Syndrome
26%
Brain Natriuretic Peptide
26%
Retrotransposon
26%
DNA Sequence
26%
Missense Mutation
26%
Plasmid
26%
Transposase
26%
Proband
25%
Mannose
21%
Keyphrases
Dystroglycanopathy
52%
Congenital muscular Dystrophy
39%
Fukutin
32%
Fukuyama Congenital muscular Dystrophy
30%
Cochlear Nerve
26%
Congenital Hearing Impairment
26%
Muscle Analysis
26%
Late-onset
26%
Very Low Birth Weight Infant
26%
Bilirubin Monitoring
26%
Transcutaneous Bilirubin
26%
CRISPR Interference (CRISPRi)
26%
Enterovirus D68 (EV-D68)
26%
RNA Foci
26%
Cryptic Exon
26%
Gitelman Syndrome
26%
Dystrophin Gene
26%
Intestinal Pseudo-obstruction
26%
SLC12A3
26%
Dried Umbilical Cord
26%
Mitochondrial Respiratory Chain Complexes
26%
Complex IV Deficiency
26%
Extremely Preterm Infants
26%
α-Chain
26%
Donor Site
26%
Small-for-gestational Age
26%
Body Mass Index Trajectories
26%
Autosomal Dominant Alport Syndrome
26%
Isodisomy
26%
Corrected Age
26%
Early Life Factors
26%
Accessible Region
26%
Targeted RNA Sequencing
26%
Macrocephaly
26%
Dent Disease
26%
Ultra-deep Well
26%
Death Receptor 3
26%
Synovial Cells
26%
Non-consanguineous
26%
Consanguineous Family
26%
New-onset Refractory Status Epilepticus (NORSE)
26%
Cruciform DNA
26%
Renal Ciliopathy
26%
Targeted Resequencing
26%
Somatic Mosaicism
26%
X-linked Alport Syndrome
26%
Deep Intronic Variant
26%
Palindromic Sequence
26%
Mechanistic Aspects
26%
Inherited Glycosylphosphatidylinositol Deficiencies
26%
Medicine and Dentistry
Bilirubin
52%
Acute Brain Disease
52%
Fukuyama Congenital Muscular Dystrophy
52%
Duchenne Muscular Dystrophy
26%
Low-Birthweight Infant
26%
Ultrasonography of Muscle
26%
Very Low Birth Weight
26%
Enterovirus D68
26%
Pervasive Developmental Disorder
26%
Alpha Chain
26%
Respiratory Chain
26%
Cytochrome C Oxidase Deficiency
26%
Alport Syndrome
26%
Intestinal Pseudoobstruction
26%
GRIN2B
26%
Macrocephaly
26%
Induced Pluripotent Stem Cell
26%
Status Epilepticus
26%
Congenital Cytomegalovirus Infection
26%
Pantothenate Kinase-Associated Neurodegeneration
26%
Leigh's Disease
26%
Adams Oliver Syndrome
26%
Distal Renal Tubular Acidosis
26%
Consensus Sequence
26%
Survival Motor Neuron Protein
26%
Umbilical Cord-Derived Mesenchymal Stem Cell
26%
Rotavirus Vaccine
26%
Acute Gastroenteritis
26%
Fosphenytoin
26%
Anaphylaxis
26%
MNGIE Syndrome
26%
Ligase
26%
Merosin
26%
Fibronectin
26%
Melanocyte
26%
Disease
26%
Symptom
26%
Glomerulopathy
26%
Meta-Analysis
26%
Systematic Review
26%
Neonatal Infant
26%
Precursor
26%
Pediatrics
24%
Spinal Muscular Atrophy
22%
Brain Function
15%
Purpura fulminans
13%
Barbiturate
13%
Pathogenicity
13%
Heparin
13%
Hyperbilirubinemia
10%
